APA (7th ed.) Citation

Alberico L. Catapano MD, P., Michal Vrablik MD, P., Yuri Karpov MD, Baptiste Berthou Lic, Megan Loy BAppSc, & Marie Baccara-Dinet MD. (2022). A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins. SAGE Publishing.

Chicago Style (17th ed.) Citation

Alberico L. Catapano MD, PhD, PhD Michal Vrablik MD, Yuri Karpov MD, Baptiste Berthou Lic, Megan Loy BAppSc, and Marie Baccara-Dinet MD. A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins. SAGE Publishing, 2022.

MLA (9th ed.) Citation

Alberico L. Catapano MD, PhD, et al. A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins. SAGE Publishing, 2022.